This market has grown explosively, projected to expand from 4.1 billion dollars to 13 billion by 2035
Research indicates that although semaglutide did not significantly improve hepatic fibrosis, it had positive effects on hepatic steatosis, weight control, and diabetes-related parameters, offering a new therapeutic direction for patients with NASH and compensated cirrhosis (Flint et al., 2021
Side Effect Management: Our providers monitor for gastrointestinal symptoms like nausea, reflux, or constipation, providing medical strategies to mitigate them before they become severe
GPX enzymes are ubiquitous in the body and previous studies have shown a decrease in glutathione peroxidase 4 (GPX4) in patients with NEC
Hainerov I, Larsen LH, Holst B, et al